Baptiste Michel Rode

Title: Baptiste Michel Rode: Innovator in TRPC Ion Channel Inhibitors

Introduction

Baptiste Michel Rode is a notable inventor based in Bordeaux, France. He has made significant contributions to the field of medical therapy through his innovative work on TRPC ion channel inhibitors. His research focuses on addressing critical health issues such as obesity and insulin resistance.

Latest Patents

Baptiste Michel Rode holds a patent for "TRPC ion channel inhibitors for use in therapy." This patent describes inhibitors of Transient Receptor Potential Canonical (TRPC) ion channels, specifically targeting TRPC4 and TRPC5 proteins. These inhibitors are designed to combat obesity and other medical conditions, including insulin resistance associated with Type II diabetes, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). Additionally, the patent discloses the use of these inhibitors for cosmetic purposes, such as cosmetic weight loss. He has 1 patent to his name.

Career Highlights

Baptiste Michel Rode is affiliated with the University of Leeds, where he continues to advance his research in the field of ion channel inhibitors. His work has the potential to impact various therapeutic areas, making him a valuable contributor to medical science.

Collaborations

Some of his notable coworkers include Richard James Foster and David John Beech, who collaborate with him on various research projects.

Conclusion

Baptiste Michel Rode is an influential inventor whose work on TRPC ion channel inhibitors is paving the way for new therapeutic approaches to combat obesity and related medical conditions. His contributions to the field are significant and hold promise for future advancements in medical therapy.